Leading Molecular Diagnostics Company BillionToOne Raises $130 Million in Oversubscribed Series D Funding Over $1B+ Valuation

Posted on by

The financing will further scale BillionToOne’s prenatal screening and oncology diagnostics businesses MENLO PARK, Calif., June 21, 2024 /PRNewswire/ — BillionToOne, a next-generation molecular diagnostics company, announced today that it has raised $130 million in an oversubscribed,…

Posted in UncategorizedTagged
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.